Osaic Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Osaic Holdings's REGN Position: Q2 2026 in Review
Osaic Holdings increased its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q2 2026, buying an estimated $126K and bringing the position to 12,423 shares worth $7.75M. The position accounts for 0.01% of the portfolio, ranked #1214.
Osaic Holdings first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $14.9M in Q3 2023. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Osaic Holdings held 12,423 shares of Regeneron Pharmaceuticals worth $7.75M as of Q2 2026.
- Osaic Holdings bought 185 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $126K.
- Regeneron Pharmaceuticals made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1214 holding.
- Osaic Holdings first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's Regeneron Pharmaceuticals position peaked at $14.9M in Q3 2023.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.